LATAMBif Registry: January 2021 Report

The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace. The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice. 

Bellow you will find data from January 2021, which includes all patients enrolled by the different Latin American centers taking part in the register. 

January data

So far, the registry has included 157 patients of mean age 65 (+- 10.86): 85% men, and 15% women.

Among the risk factors, we have found 84,6% had a history of hypertension, 78,2% dyslipidemia, 12,2% were smokers, 17,9% had type 2 diabetes and 2,6% had type 1 diabetes. In addition, 42,9% had prior PCI, 7,1% prior CABG and 26,9% prior MI.

Registro LATAM BIF - Reporte Mensual Enero 2021

Of all included patients, 37,2% presented chromic coronary syndrome, 26,9% unstable angina, 16,7% Non-ST acute myocardial infarction (NSTEMI), 12,2% were asymptomatic (silent ischemia) 7,1 ST elevation MI (STEMI).

As regards clinical indications, 55,1% received elective indication, 35,3% urgent indication and 9,6 emergency indication.

83,2% of vascular access was transradial (proximal), 3,9% transradial (distal) and12,9% femoral.

Registro Latam Bif - Reporte Mensual Enero 2021 - 2

As to the initial strategy, 71% was the provisional stent technique and 29% the two stent technique.

Registro Latam Bif - Reporte Mensual Enero 2021 - 3
monthly-report-january-2021

How to make part of the LATAM Bif Registry?

Write to latambif@gmail.com. You will receive all the information and documentation required for LATAMBif, coordinated by SOLACI Research.

Why take part in LATAM Bif?

  1. The chance to access your own database dedicated to coronary bifurcations, with unified variables for all centers across Latin America. 
  2. Each center will own their data and will be able to analyze outcomes in real time. 
  3. The chance to interact with centers interested in research and publication throughout the region. 
  4. The chance to present at local and international events the outcomes of LATAM Bif Registry.
  5. In case you might need help to develop research projects and/or carry out statistical analysis, you will have the support of SOLACI Research.
  6. SOLACI Research will provide weekly auditing for all data, initial and annual (mandatory followup), for it to be charged correctly. 

Write now to latambif@gmail.com and start participating of LATAM Bif.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...